These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30793348)

  • 1. Treating opioid-induced constipation in patients taking other medications: Avoiding CYP450 drug interactions.
    Raffa RB; Taylor R; Pergolizzi JV
    J Clin Pharm Ther; 2019 Jun; 44(3):361-371. PubMed ID: 30793348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
    Streicher JM; Bilsky EJ
    J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K; Halawi H; Camilleri M
    Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs.
    Li Z; Pergolizzi JV; Huttner RP; Zampogna G; Breve F; Raffa RB
    J Clin Pharm Ther; 2015 Dec; 40(6):615-9. PubMed ID: 26573866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigational opioid antagonists for treating opioid-induced bowel dysfunction.
    Mozaffari S; Nikfar S; Abdollahi M
    Expert Opin Investig Drugs; 2018 Mar; 27(3):235-242. PubMed ID: 29266973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripherally acting μ-opioid antagonist for the treatment of opioid-induced constipation: Systematic review and meta-analysis.
    Nishie K; Yamamoto S; Yamaga T; Horigome N; Hanaoka M
    J Gastroenterol Hepatol; 2019 May; 34(5):818-829. PubMed ID: 30597600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R; Prommer E; Backstedt D
    Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Peripheral μ-Opioid Receptor Antagonists for Treating Opioid-Induced Constipation among US Medicare Beneficiaries from 2014 to 2018.
    Premnath N; Sumarsono A; Sedhom R; Johnson DH; Subbiah IM; Dy SM; Gupta A
    J Palliat Med; 2021 Aug; 24(8):1236-1239. PubMed ID: 33872062
    [No Abstract]   [Full Text] [Related]  

  • 9. [Opioid-Induced Constipation in Patients with Cancer Pain].
    Aruga E
    Gan To Kagaku Ryoho; 2021 Nov; 48(11):1311-1315. PubMed ID: 34795117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Peripherally Acting Mu-Opioid Receptor Antagonists for the Treatment of Opioid-Induced Constipation: A Bayesian Network Meta-analysis.
    Ouyang R; Li Z; Huang S; Liu J; Huang J
    Pain Med; 2020 Nov; 21(11):3224-3232. PubMed ID: 32488259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis.
    Essmat N; Karádi DÁ; Zádor F; Király K; Fürst S; Al-Khrasani M
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?
    Holzer P
    Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety.
    Pergolizzi JV; Christo PJ; LeQuang JA; Magnusson P
    Drug Des Devel Ther; 2020; 14():1009-1025. PubMed ID: 32210534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating Opioid-Induced Constipation in Older Adults: New Options.
    Sani H; Mahan RJ
    Consult Pharm; 2015 Oct; 30(10):612-5. PubMed ID: 26450143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
    White WB; Kowey P; Diva U; Sostek M; Tummala R
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic treatment of opioid-induced constipation.
    Wang CZ; Yuan CS
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1225-7. PubMed ID: 23834367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripherally Acting μ-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review.
    Chamie K; Golla V; Lenis AT; Lec PM; Rahman S; Viscusi ER
    J Gastrointest Surg; 2021 Jan; 25(1):293-302. PubMed ID: 32779081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-induced Constipation: A Review of Health-related Quality of Life, Patient Burden, Practical Clinical Considerations, and the Impact of Peripherally Acting μ-Opioid Receptor Antagonists.
    Argoff CE
    Clin J Pain; 2020 Sep; 36(9):716-722. PubMed ID: 32554978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the recognition and diagnosis of opioid-induced constipation in clinical practice.
    Gupta A
    J Fam Pract; 2015 Oct; 64(10 Suppl 1):. PubMed ID: 26561554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-Related Constipation.
    Liu JJ; Brenner DM
    Gastroenterol Clin North Am; 2022 Mar; 51(1):107-121. PubMed ID: 35135657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.